Relationship between blood glucose levels and diabetic neuropathy examination score in patients with diabetes mellitus

Eunice Keren Singarayar; Tamilarasan Anthoni Josephrajan; Prakash Jayabalan

doi:10.18203/2320-6012.ijrms20250984

Authors

Eunice Keren Singarayar KMCH College of Physiotherapy, Coimbatore, Tamilnadu, India
Tamilarasan Anthoni Josephrajan KMCH College of Physiotherapy, Coimbatore, Tamilnadu, India
Prakash Jayabalan KMCH College of Physiotherapy, Coimbatore, Tamilnadu, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20250984

Keywords:

High blood sugar individuals, DNE score, Symptoms of diabetic neuropathy

Abstract

Background: Diabetic neuropathy is a specific type nerve damage that primarily affects the peripheral nervous system, causing a loss of sensation in the extremities, disruption of autonomic functions, and to a lesser extent, motor function. The length of time a person has diabetes and their haemoglobin A1C (HbA1C) levels (a measure of glycated haemoglobin which reflects average daily glucose levels) are significant factors in determining the development of diabetic neuropathy.

Methods: This was a cross-sectional study conducted between April 2023- July 2023 among 51 participants who met the selection criteria participated in the study and were assessed using the Diabetic Neuropathy Examination Score (DNE score).

Results: The study concluded that the symptoms of diabetic neuropathy in high blood sugar individuals are higher in males (59%) than females (41%) due to changes in blood sugar levels. A direct correlation found amidst blood glucose volume and diabetic neuropathy examination (DNE score).

Conclusion: Hence the study concluded that the symptoms of glycated haemoglobin neuropathy in diabetes patients are higher in males (59%) than females (41%) due to changes in blood sugar levels.

Metrics

Metrics Loading ...

References

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care. 2013;36(1):67-74. DOI: https://doi.org/10.2337/dc13-S067

Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, et al. Diabetic neuropathy. Nature reviews Disease primers. 2019;5(1):41. DOI: https://doi.org/10.1038/s41572-019-0092-1

Sun J, Wang Y, Zhang X, Zhu S, He H. Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis. Primary Care Diabetes. 2020;14(5):435–444. DOI: https://doi.org/10.1016/j.pcd.2019.12.005

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(1):62-9. DOI: https://doi.org/10.2337/dc10-S062

Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150-4. DOI: https://doi.org/10.1007/BF00400697

Valk GD, Nauta JJ, Strijers RL, Bertelsmann FW. Clinical examination versus neurophysiological examination in the diagnosis of diabetic polyneuropathy. Diabetic medicine. 1992;9(8):716-21. DOI: https://doi.org/10.1111/j.1464-5491.1992.tb01879.x

Nathan DM, Turgeon H, Regan S. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia. 2007;50:2239-44. DOI: https://doi.org/10.1007/s00125-007-0803-0

Afifi L, Abdelalim AM, Ashour AS, Al-Athwari A. Correlation between clinical neuropathy scores and nerve conduction studies in patients with diabetic peripheral neuropathy. The Egyptian J of Neurology, Psychiatry and Neurosurg. 2016;53(4):248. DOI: https://doi.org/10.4103/1110-1083.202386

Committee TI. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes care. 2009;32(7):1327. DOI: https://doi.org/10.2337/dc09-9033

Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual haemoglobin in patients with diabetes mellitus. Biochem Biophysical Res Communications. 1969;36(5):838-43. DOI: https://doi.org/10.1016/0006-291X(69)90685-8

Ghosh LM, Mannari JG. Reliability of diabetic neuropathy symptom and diabetic neuropathy examination scoring system for the diagnosis of diabetic peripheral neuropathy in type 2 diabetes mellitus patients. Int J Res in Med Sci. 2020;8(1):327. DOI: https://doi.org/10.18203/2320-6012.ijrms20195931

Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort: the Rochester Diabetic Neuropathy Study. Neurol. 1993;43(4):817-9. DOI: https://doi.org/10.1212/WNL.43.4.817

Dyck PJ, Sherman WR, Hallcher LM, John Service F. Human diabetic endoneurial sorbitol, fructose, and myo‐inositol related to sural nerve morphometry. Annals of Neurology: Official J of the American Neurological Association and the Child Neurol Soci. 1980;8(6):590-6. DOI: https://doi.org/10.1002/ana.410080608

Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res and Clin Prac. 2000;47(2):123-8. DOI: https://doi.org/10.1016/S0168-8227(99)00112-6

Smieja M, Hunt DL, Edelman D, Etchells E, Cornuz J, Simel DL. International Cooperative Group for Clinical Examination Research. Clinical examination for the detection of protective sensation in the feet of diabetic patients. J General Internal Med. 1999;14(7):418-24. DOI: https://doi.org/10.1046/j.1525-1497.1999.05208.x

Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. A1c-Derived Average Glucose (ADAG) Study Group. Translating the A1C assay into estimated average glucose values. Diabetes care. 2009;31(8):1473-8. DOI: https://doi.org/10.2337/dc08-0545

Meijer JW, Bosma E, Lefrandt JD, Links TP, Smit AJ, Stewart RE, Van Der Hoeven JH, Hoogenberg K. Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores. Diabetes care. 2003;26(3):697-701. DOI: https://doi.org/10.2337/diacare.26.3.697

Weerasuriya N, Siribaddana S, Dissanayake A, Subasinghe Z, Wariyapola D, Fernando DJ. Long-term complications in newly diagnosed Sri Lankan patients with type 2 diabetes mellitus. QJM: monthly J of the Association of Phys. 1998;91(6):439-43. DOI: https://doi.org/10.1093/qjmed/91.6.439

Pahadia R, Moolrajani M. Comparative study of diabetic neuropathy examination scoring &nerve conduction velocity in patients of diabetic neuropathy. International J of Health and Clinical Res. 2021;4(8):286–9.

Brownrigg JR, Apelqvist J, Bakker K, Schaper NC, Hinchliffe RJ. International Working Group on the Diabetic Foot. Evidence-based management of PAD & the diabetic foot. Eur J Vasc Endovasc Surg. 2013;46(6):673-85. DOI: https://doi.org/10.1016/j.ejvs.2013.02.014

Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956-62. DOI: https://doi.org/10.2337/diacare.28.4.956

Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285-93. DOI: https://doi.org/10.2337/dc10-1303

Pop-Busui R, Lu J, Lopes N, Jones TL. BARI 2D Study Group. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J Peripheral Nerv System. 2009;14(3):1-3. DOI: https://doi.org/10.1111/j.1529-8027.2009.00200.x

Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, Walker J, et al. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. The Lancet Diabetes Endocrinol. 2019;7(12):938-48. DOI: https://doi.org/10.1016/S2213-8587(19)30081-6

Zhang H, Chen Y, Zhu W, Niu T, Song B, Wang H. The mediating role of HbA1c in the association between elevated low-density lipoprotein cholesterol levels and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. Lipids Health Disease. 2023;22(1):102. DOI: https://doi.org/10.1186/s12944-023-01865-5

Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019;19(10):86. DOI: https://doi.org/10.1007/s11892-019-1212-8

Martin CL, Albers JW, Pop-Busui R; DCCT/EDIC Research Group. Neuropathy and related findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care. 2014;37(1):31-8. DOI: https://doi.org/10.2337/dc13-2114

Vinik AI, Nevoret ML, Casellini C, Parson H. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013;42(4):747-87. DOI: https://doi.org/10.1016/j.ecl.2013.06.001

Deli G, Bosnyak E, Pusch G, Komoly S, Feher G. Diabetic neuropathies: Diagnosis and management. Neuroendocrinology. 2013;98(4):267-80. DOI: https://doi.org/10.1159/000358728

Vianni DD, Subramanian SS, Vishnuram S, Razali H, Sekar M, Alyahyawi N, et al. Exploring the relationship between glycated haemoglobin levels and geriatric syndromes in elderly patients with diabetes: a cross-sectional study. Fizjoterapia Polska. 2024;24(5):293-9. DOI: https://doi.org/10.56984/8ZG020CN4TC